| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $200,000 | 1 | 100 |
Sells | $0 | 0 | 0 |
| Feehery William F | CHIEF EXECUTIVE OFFICER | 1 | $200,000 | 0 | $0 | $200,000 |
Certara, Inc. provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. From initial drug discovery and preclinical research to clinical trials, regulatory submissions, and market entry, the company's core mission is to accelerate the delivery of new medicines to patients by transforming these processes with its innovative biosimulation software and expertise. Its extensive portfolio of technology-enabled services includes mechanistic and empirical …
Over the last 12 months, insiders at Certara, Inc. have bought $200,000 and sold $0 worth of Certara, Inc. stock.
On average, over the past 5 years, insiders at Certara, Inc. have bought $340,486 and sold $221.11M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Feehery William F (CHIEF EXECUTIVE OFFICER) — $200,000.
The last purchase of 24,096 shares for transaction amount of $200,000 was made by Feehery William F (CHIEF EXECUTIVE OFFICER) on 2025‑11‑11.
| 2025-11-11 | Feehery William F | CHIEF EXECUTIVE OFFICER | 24,096.38 0.0143% | $8.30 | $200,000 | -9.67% | ||
| 2025-09-09 | Sale | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | 51,224 0.0318% | $10.92 | $559,366 | -27.55% | |
| 2024-10-07 | Sale | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | 5,409 0.0035% | $11.03 | $59,661 | +1.13% | |
| 2024-09-09 | Sale | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | 51,224 0.0313% | $11.29 | $578,319 | -3.31% | |
| 2024-04-02 | Sale | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | 14,427 0.009% | $16.85 | $243,161 | -27.26% | |
| 2024-04-01 | Sale | Traynor Richard M. | SVP AND GENERAL COUNSEL | 3,000 0.0019% | $18.00 | $54,000 | -31.22% | |
| 2024-03-04 | Sale | Traynor Richard M. | SVP AND GENERAL COUNSEL | 3,000 0.0018% | $18.28 | $54,840 | -29.42% | |
| 2024-02-20 | Sale | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | 5,000 0.0032% | $18.00 | $90,000 | -21.29% | |
| 2024-02-12 | Sale | Traynor Richard M. | SVP AND GENERAL COUNSEL | 6,000 0.0038% | $18.00 | $108,000 | -23.76% | |
| 2023-12-26 | Sale | Traynor Richard M. | SVP AND GENERAL COUNSEL | 6,000 0.0037% | $18.00 | $108,000 | -14.51% | |
| 2023-09-11 | Sale | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | 51,224 0.0321% | $14.60 | $747,870 | +9.96% | |
| 2023-08-22 | BROSHY ERAN | director | 4,807 0.003% | $15.80 | $75,951 | +2.74% | ||
| 2023-08-21 | BROSHY ERAN | director | 193 0.0001% | $16.10 | $3,107 | -0.06% | ||
| 2023-06-05 | Sale | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | 19,104 0.0122% | $21.55 | $411,691 | -21.81% | |
| 2023-05-11 | Sale | Traynor Richard M. | SVP AND GENERAL COUNSEL | 5,000 0.0031% | $20.82 | $104,100 | -19.53% | |
| 2023-04-14 | Sale | Traynor Richard M. | SVP AND GENERAL COUNSEL | 5,000 0.0031% | $23.66 | $118,300 | -29.43% | |
| 2023-03-06 | Sale | Traynor Richard M. | SVP AND GENERAL COUNSEL | 10,000 0.0063% | $21.45 | $214,500 | -20.13% | |
| 2023-02-02 | Sale | Traynor Richard M. | SVP AND GENERAL COUNSEL | 15,000 0.0094% | $20.00 | $300,000 | -13.42% | |
| 2022-12-08 | Sale | EQT Avatar Parent L.P. | director | 29.95M 15.9478% | $15.00 | $449.32M | +0.56% | |
| 2022-11-22 | Sale | Pedersen Leif E | PRESIDENT, SOFTWARE | 51,223 0.0322% | $15.55 | $796,518 | +14.63% |
| Feehery William F | CHIEF EXECUTIVE OFFICER | 2360769 1.5476% | $25.66M | 1 | 15 | |
| Schemick Michael Andrew | CHIEF FINANCIAL OFFICER | 517870 0.3395% | $5.63M | 1 | 6 | +7.68% |
| CASHMAN JAMES E III | director | 438782 0.2877% | $4.77M | 1 | 2 | <0.0001% |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | 173524 0.1138% | $1.89M | 1 | 21 | <0.0001% |
| WALSH MATTHEW M | director | 167901 0.1101% | $1.83M | 1 | 1 | <0.0001% |
| McLean Stephen M. | 42000 0.0275% | $456,540.00 | 2 | 0 | <0.0001% | |
| BROSHY ERAN | director | 14360 0.0094% | $156,093.20 | 2 | 0 | +1.34% |
| Increased Positions | 128 | +42.11% | 19M | +13.49% |
| Decreased Positions | 136 | -44.74% | 14M | -9.46% |
| New Positions | 54 | New | 5M | New |
| Sold Out Positions | 38 | Sold Out | 2M | Sold Out |
| Total Postitions | 296 | -2.63% | 149M | +4.03% |
| Wasatch Advisors Lp | $152,061.00 | 10.94% | 17.4M | +4M | +28.56% | 2025-09-30 |
| Blackrock, Inc. | $121,556.00 | 8.75% | 13.91M | +571,575 | +4.29% | 2025-09-30 |
| Vanguard Group Inc | $108,441.00 | 7.8% | 12.41M | -27,221 | -0.22% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $72,999.00 | 5.25% | 8.35M | +499,523 | +6.36% | 2025-09-30 |
| Arrowmark Colorado Holdings Llc | $64,488.00 | 4.64% | 7.38M | -510,886 | -6.48% | 2025-09-30 |
| Deerfield Management Company, L.P. | $58,904.00 | 4.24% | 6.74M | +3M | +71.66% | 2025-09-30 |
| Geneva Capital Management Llc | $53,845.00 | 3.88% | 6.16M | +45,859 | +0.75% | 2025-09-30 |
| Teacher Retirement System Of Texas | $49,499.00 | 3.56% | 5.66M | -10,986 | -0.19% | 2025-09-30 |
| Ameriprise Financial Inc | $43,433.00 | 3.13% | 4.97M | -491,218 | -9% | 2025-09-30 |
| State Street Corp | $33,519.00 | 2.41% | 3.84M | +174,589 | +4.77% | 2025-09-30 |